Wall Street Cuts Mosaic Again: UBS Slashes Target to $27
UBS cuts Mosaic’s price target to $27, citing squeezed phosphate margins from higher sulfur and input costs, as Wall ...
This piece analyzes whether retirement funds should favor index or target date options, emphasizing long-term planning and goal alignment.
26,209 articlesUBS cuts Mosaic’s price target to $27, citing squeezed phosphate margins from higher sulfur and input costs, as Wall ...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
A major biotech takeover bid sets the tone for today’s market. AbbVie’s cash offer for Apogee Therapeutics sent share...
Analysts convene Thursday to highlight key stock moves ahead of a holiday weekend, with fresh targets and cautions ac...
Oil markets face a persistent pricing regime, per Shell’s warning. This guide translates that view into practical inv...
Cisco surprised investors with strong quarterly results and higher guidance, boosting its stock and signaling robust ...
Prospect Capital offers a striking 20%+ yield, but its long-run performance raises questions. This article lays out a...
Berkshire Hathaway just resumed stock buybacks after a long pause, signaling a shift in capital allocation. This arti...
On May 13, the stock market today showed energy storage equities rallying after solid earnings, then retreating as tr...
A sudden burst in DRAM-focused ETFs outpaced the broader semiconductor market this month, but market watchers warn a ...
Looking for investments that could compound for 20 years? This article identifies three consumer-facing giants with d...
Rent prices dropping nationwide are reshaping tenant leverage as supply catches up with demand. This report flags whe...